Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Okairos
company
About
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20.50M
- Industries
- Biopharma,Biotechnology,Genetics,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20.50M
Okairos has raised a total of
$20.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 14, 2010 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 14, 2010 | Series B | $20.50M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Okairos is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
